Accounting Advisory Board
|
Name |
Firm |
Title |
| Georgia Loukas Demeros | Thompson Coburn LLP | Partner |
| Steven Fedea | Goldman Sach | Vice President, Wealth Management |
| Michael Hart | Ernst & Young | Partner |
| Thomas Murtagh | Forvis/Mazars | Partner |
| Beata J. Peters | Horizon Therapeutics | Vice President, Financial Planning and Analysis |
|
Jeanette Press |
Cabot Microelectronics | Chief Financial Officer, Corporate Controller and Principal Accounting Officer |
| Greg Ramenofsky | Borealis Strategic Capital Partners, LP | Chief Operating Officer |
| Karl Schachelmayer | Deloitte | Senior Manager |
| Michael Schamberger | Grant Thornton | Partner |
| Phillip Smayda | PwC | Partner |
| Graham Traynor | Trustmark Companies | Vice President and Corporate Controller |
| Patrick Unzicker | PharmaCann Inc | Chief Financial Officer |
|
Name |
Firm |
Title |
| Georgia Loukas Demeros | Thompson Coburn LLP | Partner |
| Steven Fedea | Goldman Sach | Vice President, Wealth Management |
| Michael Hart | Ernst & Young | Partner |
| Thomas Murtagh | Forvis/Mazars | Partner |
| Beata J. Peters | Horizon Therapeutics | Vice President, Financial Planning and Analysis |
|
Jeanette Press |
Cabot Microelectronics | Chief Financial Officer, Corporate Controller and Principal Accounting Officer |
| Greg Ramenofsky | Borealis Strategic Capital Partners, LP | Chief Operating Officer |
| Karl Schachelmayer | Deloitte | Senior Manager |
| Michael Schamberger | Grant Thornton | Partner |
| Phillip Smayda | PwC | Partner |
| Graham Traynor | Trustmark Companies | Vice President and Corporate Controller |
| Patrick Unzicker | PharmaCann Inc | Chief Financial Officer |